Rhetorical Analysis: Pharmaceutical Innovation In Joel Lexchin’s article “Pharmaceutical innovation: Can we live forever? A commentary on Schnittker and Karandinos” he addresses the article made by Schnittker and Karandinos about the progression of pharmaceuticals and whether or not we have advanced enough to significantly increase our life expectancy. Lexchin uses a plethora of rhetoric to persuade the reader into believing his argument, mostly relying upon logos, chiefly facts, to appeal to the logical and sensible side of the readers. His argument is not limited to logos though, as there are faint traces of pathos, the longing to live forever, as well as ethos, society’s needs for further advances, to further convince the reader. …show more content…

Word count: 815

Bibliography
Grootendorst, Paul., Piérard, Emmanuelle., and Shim, Minsup. "Life-expectancy gains from pharmaceutical drugs: a critical appraisal of the literature." Expert Review of Pharmacoeconomics & Outcomes Research 9, no. 4 (2009): 353-364.
Guyatt, Gordon H., Devereaux P. J., Lexchin, Joel., Stone, Samuel B., Yalnizyan, Armine., Himmelstein, David.,Woolhandler, Steffie., et al. "A systematic review of studies comparing health outcomes in Canada and the United States." Open Medicine 1, no. 1 (2007): e27.
Lexchin, Joel. "Pharmaceutical innovation: Can we live forever? A commentary on Schnittker and Karandinos." Social Science & Medicine 70, no. 7 (2008): 972-973. The Active Reader: Strategies for academic reading and writing (2012): 396-399.
Lichtenberg, Frank R. Sources of US longevity increase, 1960-1997. No. W8755. National Bureau of Economic Research: (2002).
Mochrie, Morgan., Mochrie, Steve., and Mochrie, Clare. "Pharmaceutical Innovation: Can health and economic goals be met?" Centre for Health Services and Policy Research (July 2008): 1-9
Schnittker, J., & Karandinos, G. (2010). Methuselah’s Medicine: Pharmaceutical innovation and mortality in the United States, 1960-2000. Social Science & Medicine, 70, 961-968

--------------------------------------------
[ 1 ]. J. Schnittker.,